Marc Rubin
Directeur/Membre du Conseil chez GALECTIN THERAPEUTICS INC.
Fortune : 51 869 $ au 31/05/2024
Profil
Marc Rubin is currently an Independent Director at Curis, Inc., an Independent Director at Galectin Therapeutics, Inc., a Director at Soricimed Biopharma, Inc., and a Director at The Rogosin Institute, Inc. He previously served as the President & Chief Executive Officer at Titan Pharmaceuticals, Inc. from 2007 to 2009.
He was also a Director at Medarex, Inc. from 2007 to 2009 and at Surface Logix LLC from 2005 to 2011.
Additionally, he held positions as the Head-Global Research & Development at Bayer Schering Pharma AG from 2006 to 2007 and at Bayer Pharma AG from 2007 to 2007.
Dr. Rubin has a doctorate degree from Weill Cornell Medical College, which he obtained in 1980.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/02/2024 | 13 581 ( 0,02% ) | 36 940 $ | 31/05/2024 | |
CURIS, INC.
0,02% | 21/05/2024 | 1 441 ( 0,02% ) | 14 929 $ | 31/05/2024 |
Postes actifs de Marc Rubin
| Sociétés | Poste | Début |
|---|---|---|
| GALECTIN THERAPEUTICS INC. | Directeur/Membre du Conseil | 04/06/2018 |
| CURIS, INC. | Directeur/Membre du Conseil | 03/06/2010 |
The Rogosin Institute, Inc.
 The Rogosin Institute, Inc. Medical/Nursing ServicesHealth Services The Rogosin Institute, Inc. engages in providing treatment for kidney diseases. The company was founded in 1983 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Soricimed Biopharma, Inc.
 Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Directeur/Membre du Conseil | 19/03/2018 |
Anciens postes connus de Marc Rubin
| Sociétés | Poste | Fin |
|---|---|---|
| TITAN PHARMACEUTICALS, INC. | Président | 15/08/2022 |
Surface Logix LLC
 Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/01/2011 |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Directeur/Membre du Conseil | 27/08/2009 |
| TITAN PHARMACEUTICALS, INC. | Directeur Général | 01/01/2009 |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Directeur Technique/Scientifique/R&D | 01/02/2007 |
Formation de Marc Rubin
| Weill Cornell Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TITAN PHARMACEUTICALS, INC. | Health Technology |
| CURIS, INC. | Health Technology |
| GALECTIN THERAPEUTICS INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 12 |
|---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Schering Berlin, Inc.
 Schering Berlin, Inc. Medical SpecialtiesHealth Technology Part of Bayer AG, Schering Berlin, Inc. is a company that manufactures pharmaceuticals and diagnostic substances. The company is based in Whippany, NJ. | Health Technology |
| Bayer Schering Pharma AG | Health Technology |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Surface Logix LLC is a drug development company which involves biophysical chemistry to create new small molecule drugs. It creates chemical entities and focuses on cardiovascular and metabolic diseases. The company was founded by George M. Whitesides and Carmichael S. Roberts, Jr. and is headquartered in Cambridge, MA. | Health Technology |
Xequel Bio, Inc.
 Xequel Bio, Inc. Pharmaceuticals: MajorHealth Technology Xequel Bio, Inc. operates as a biopharmaceutical company. It develops drugs and medical applications for scar prevention, inflammation reduction, wound healing, and complex tissue regeneration. The company was founded by Gautam Sudhir Ghatnekar in 2005 and is headquartered in Mount Pleasant, SC. | Health Technology |
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Health Technology |
Gemmus Pharma, Inc.
 Gemmus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Gemmus Pharma Inc. develops pharmaceutical products for the treatment of infectious diseases. The firm focus on the development of pharmaceutical products for the treatment of influenza and other viral infectious diseases. It develops GP1001, a non-peptidic eiconsanoid analog that is used for the treatment of serious influenza infections that require hospitalization as either a stand-alone treatment or co-therapy with an antiviral drug, as oseltamivir. The company was founded by Daryl H. Faulds in 2007 and is headquartered in San Francisco, CA. | Health Technology |
North Shore Medical Center, Inc.
 North Shore Medical Center, Inc. Hospital/Nursing ManagementHealth Services North Shore Medical Center provides healthcare services. It offers nutrition counseling, pain management, primary care, emergency medicine, home care, laboratory services, mammography, diabetes management, physical medicine and rehabilitation, and more. The company was founded in 1952 and is headquartered in Salem, MA. | Health Services |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
| Berlex Pharmaceuticals, Inc. | |
The Rogosin Institute, Inc.
The Rogosin Institute, Inc. Medical/Nursing ServicesHealth Services The Rogosin Institute, Inc. engages in providing treatment for kidney diseases. The company was founded in 1983 and is headquartered in New York, NY. | Health Services |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Health Services |
